JPRN-jRCT1050230133RecruitingUnknown
Measurement of biomarkers using existing samples from Phase 1 study of EA3571 in healthy adult subjects (EA3571-CP1)
Takeuchi Yutaka0 sites21 target enrollmentStarted: November 21, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 21
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- >= 20age old to < 45age old (—)
- Sex
- Male
Inclusion Criteria
- •Subjects who received multiple doses of placebo-or EA3571 in a Phase 1 study of EA3571 in healthy adult subjects
Exclusion Criteria
- •Subjects who refused to participate in this study
Investigators
Similar Trials
Completed
Not Applicable
Observational study on the detection of biomarkers of diseases of the respiratory system by means of ion mobility spectrometry.J98.8U07.1Other specified respiratory disordersCOVID-19, virus identifiedDRKS00025842Immanuel Klinikum Bernau Herzzentrum Brandenburg Hochschulklinikum der Medizinischen Hochschule Brandenburg137
Recruiting
Not Applicable
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125
Suspended
Not Applicable
A study exploring new biomarkers by measuring the rest-activity rhythms of patients with schizophrenia and mood disordersSchizophrenia and mood disordersJPRN-UMIN000045175Fujita Health University90
Completed
Not Applicable
Biomarker study; study to identify biomarkers for protein intake, a randomized, fully controlled feeding studyGeen aandoeningenUitscheiding van biomerkers na het eten van eiwit in het gezond menselijk lichaamBiomarkers of protein intakeNL-OMON36525Wageningen Universiteit25
Completed
Not Applicable
A study of cell signalling biomarkers in patients with tuberous sclerosisISRCTN62388748Aeovian Pharmaceuticals Inc.14